Home/Filings/4/0001493152-24-018282
4//SEC Filing

Finley John David 4

Accession 0001493152-24-018282

CIK 0001357459other

Filed

May 7, 8:00 PM ET

Accepted

May 8, 6:36 PM ET

Size

16.8 KB

Accession

0001493152-24-018282

Insider Transaction Report

Form 4
Period: 2024-05-06
Finley John David
DirectorCEO, CFO
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.01

    2024-05-06+2326,688 total
  • Tax Payment

    Common Stock, par value $0.01

    2024-05-06$8.46/sh67$5676,621 total
  • Exercise/Conversion

    Common Stock, par value $0.01

    2024-05-06+2116,832 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-062321,622 total
    Common Stock (232 underlying)
  • Tax Payment

    Common Stock, par value $0.01

    2024-05-06$8.46/sh61$5166,771 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-062112,111 total
    Common Stock (211 underlying)
Holdings
  • Common Stock, par value $0.01

    (indirect: By LLC)
    51
Footnotes (8)
  • [F1]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023.
  • [F2]Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.
  • [F3]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.
  • [F4]Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.
  • [F5]Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
  • [F6]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
  • [F7]This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.
  • [F8]This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

Documents

1 file

Issuer

PALISADE BIO, INC.

CIK 0001357459

Entity typeother

Related Parties

1
  • filerCIK 0001851034

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 6:36 PM ET
Size
16.8 KB